<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0, minimum-scale=1.0, user-scalable=no" />
        <title>Full STD Tx Guidelines</title>
        <link href="../jquery-mobile/jquery.mobile.theme-1.3.1.min.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.f.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.j.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/custom_arrow.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.structure-1.3.1.min.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/full.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/recreated_tables.css" rel="stylesheet" type="text/css"/>
        <script src="../jquery-mobile/jquery-1.9.1.min.js" type="text/javascript"></script>
        <script src="../../jquery-customization.js" type="text/javascript"></script>
        <script src="../jquery-mobile/jquery.mobile-1.3.1.min.js" type="text/javascript"></script>
        <script src="../../cordova-2.7.0.js" type="text/javascript" charset="utf-8"></script>
        <script src="../assets/js/metrics.js" type="text/javascript" charset="utf-8"></script>
    </head>
    <body onload="onLoad()">
        <!-- Start of page -->
        <div data-role="page" id="g171" data-theme="d">
            <div data-role="header" data-id="guidelines-header" data-theme="j" data-position="fixed">
                <a href="lv-169.html" data-role="button" data-iconshadow="false" data-corners="false" data-theme="reset" data-transition="fade" class="back_button" role="button" aria-label="back"></a>
                <h1>Full STD Tx Guidelines</h1>
	            <a href="../menu.html"  rel="external" data-role="button" data-theme="reset" data-transition="fade" data-iconshadow="false" data-corners="false" class="menu_button ui-btn-right" role="button" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-47.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-156.html" >Diseases Characterized by Genital, Anal, or Perianal Ulcers</a><span class="carrot"> > </span>
                    <a href="lv-166.html" >Congenital Syphilis</a><span class="carrot"> > </span>
                    <a href="lv-166.html" >Evaluation and Treatment of older Infants and Children</a><span class="carrot"> > </span>
                    <a href="lv-169.html" >Special Considerations</a><span class="carrot"> > </span>Penicillin Shortage
            </div>
            </br><h5 class="sgc-1" id="sigil_toc_id_171">
 Penicillin Shortage
</h5>
<p>
 During periods when the availability of penicillin is compromised, the following is recommended (see
 <a href="http://www.cdc.gov/nchstp/dstd/penicillinG.htm" onclick="openLink('http://www.cdc.gov/nchstp/dstd/penicillinG.htm');" rel="external" target="_blank">
  http://www.cdc.gov/nchstp/dstd/penicillinG.htm
 </a>
 ).
</p>
<p>
 1. For infants with clinical evidence of congenital syphilis (Scenario 1), check local sources for aqueous crystalline penicillin G (potassium or sodium). If IV penicillin G is limited, substitute some or all daily doses with procaine penicillin G (50,000 U/kg/dose IM a day in a single daily dose for 10 days).
</p>
<p>
 If aqueous or procaine penicillin G is not available, ceftriaxone (in doses appropriate for age and weight) can be considered with careful clinical and serologic follow-up. Ceftriaxone must be used with caution in infants with jaundice. For infants aged &ge;30 days, use 75 mg/kg IV/IM a day in a single daily dose for 10&ndash;14 days; however, dose adjustment might be necessary based on current weight. For older infants, the dose should be 100 mg/kg a day in a single daily dose. Evidence is insufficient&nbsp;to support the use of ceftriaxone for the treatment of congenital syphilis. Therefore, ceftriaxone should be used in consultation with a specialist in the treatment of infants with congenital syphilis. Management may include a repeat CSF examination at age 6 months if the initial examination was abnormal.
</p>
<p>
 2. For infants without any clinical evidence of infection (Scenario 2 and Scenario 3), use&nbsp;
</p>
<p>
 a. procaine penicillin G, 50,000 U/kg/dose IM a day in&nbsp;a single dose for 10 days; or
</p>
<p>
 b. benzathine penicillin G, 50,000 U/kg IM as a single&nbsp;dose.&nbsp;
</p>
<p>
 If any part of the evaluation for congenital syphilis&nbsp;is abnormal, CSF examination is not interpretable, CSF examination was not performed, or follow-up is uncertain, procaine penicillin G is recommended. A single dose of ceftriaxone is inadequate therapy.
</p>
<p>
 3. For premature infants who have no other clinical evidence of infection (Scenario 2 and Scenario 3) and might not tolerate IM injections because of decreased muscle mass, IV ceftriaxone can be considered with careful clinical and serologic follow-up (see Penicillin Shortage, Number 1). Ceftriaxone dosing must be adjusted according to age and birth weight.
</p>

            </div>
            <script type="text/javascript">
                $('#g171').on('pageshow', function (event, ui) {
                    document.addEventListener("deviceready", function(){
                        trackFullGuidelinesPageView('171');
                                                },true);
                });
            </script>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

